Literature DB >> 9754828

Evidence for a circadian rhythm of insulin release from perifused rat pancreatic islets.

E Peschke1, D Peschke.   

Abstract

This study aims to analyse a circadian rhythm of insulin secretion from isolated rat pancreatic islets in vitro and its potential modulation by melatonin, the concentrations of which change in vivo inversely to that of insulin. The circadian rhythm was evaluated in a perifusion system, adapted to the specific conditions of pancreatic islets. To determine rhythmicity of insulin secretion, 30-min fractions were collected continuously for investigative periods of 44 to 112 h. Insulin secretion in 10 experiments was analysed by using the MacAnova-program for period length (tau), the chi2-periodogram for test of significance (p < 0.001), and additionally the empirical cosine adaptation for amplitude and goodness-of-fit. Thereby a circadian pattern was observed with periods (tau) between 21.8 and 26.2 h. The period duration (mean +/- SEM) was 23.59 +/- 0.503 h, the overall mean insulin release 1038 +/- 13 pmol/l and the mean amplitude 88 +/- 17 pmol/l. Adding melatonin (10 nmol/l, t = 2 h) as a hormonal Zeitgeber during analysis of circadian insulin secretion phase-response studies show phase-shifts with approximately 9 h phase advance. Thereafter the circadian period was maintained, while the amplitude was enhanced. From this it is concluded that an endogenous circadian oscillator is located within the pancreatic islets of the rat that regulates circadian insulin secretion of the insulin-producing beta cells. The pacemaker is remarkably stable, because its periodicity is not affected by factors altering insulin secretion. In agreement with inhibitory influences of melatonin (range 0.5 nmol/l to 5 micromol/l) on the insulin response in vitro, the phase-responses support the contention that pancreatic beta cells may be targets for melatonin action.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9754828     DOI: 10.1007/s001250051034

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  46 in total

1.  Calcium and glycolysis mediate multiple bursting modes in pancreatic islets.

Authors:  Richard Bertram; Leslie Satin; Min Zhang; Paul Smolen; Arthur Sherman
Journal:  Biophys J       Date:  2004-09-03       Impact factor: 4.033

2.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

3.  Circadian genes and insulin exocytosis.

Authors:  Biliana Marcheva; Kathryn Moynihan Ramsey; Joseph Bass
Journal:  Cell Logist       Date:  2011-01

4.  A clock ticks in pancreatic beta cells.

Authors:  Jun Yoshino; Shin-Ichiro Imai
Journal:  Cell Metab       Date:  2010-08-04       Impact factor: 27.287

5.  Adrenal glucocorticoids have a key role in circadian resynchronization in a mouse model of jet lag.

Authors:  Silke Kiessling; Gregor Eichele; Henrik Oster
Journal:  J Clin Invest       Date:  2010-06-23       Impact factor: 14.808

6.  Role of melatonin on diabetes-related metabolic disorders.

Authors:  Javier Espino; José A Pariente; Ana B Rodríguez
Journal:  World J Diabetes       Date:  2011-06-15

Review 7.  Circadian metabolism in the light of evolution.

Authors:  Zachary Gerhart-Hines; Mitchell A Lazar
Journal:  Endocr Rev       Date:  2015-04-30       Impact factor: 19.871

Review 8.  Chronobiology in mammalian health.

Authors:  Zhihua Liu; Guiyan Chu
Journal:  Mol Biol Rep       Date:  2012-12-06       Impact factor: 2.316

9.  Continuous operation of microfabricated electrophoresis devices for 24 hours and application to chemical monitoring of living cells.

Authors:  Kendra R Reid; Robert T Kennedy
Journal:  Anal Chem       Date:  2009-08-15       Impact factor: 6.986

Review 10.  The islet circadian clock: entrainment mechanisms, function and role in glucose homeostasis.

Authors:  K Rakshit; J Qian; C S Colwell; A V Matveyenko
Journal:  Diabetes Obes Metab       Date:  2015-09       Impact factor: 6.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.